Assessment of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing bivalirudin versus unfractionated heparin infusion: The MATRIX (minimizing adverse hemorrhagic events by transradial access site and angioX) OCT study.
Luis A Mansilla ÁlvarezMarianna AdamoMohammad SoudOmar YacobAndrea PicchiGennaro SardellaEnrico FrigoliUgo LimbrunoStefano RigattieriRoberto DilettiGiacomo G BoccuzziMarco ZimarinoMarco ContariniFilippo RussoPaolo CalabròGiuseppe AndòFerdinando VarbellaStefano GarducciCataldo PalmieriCarlo BriguoriAlexios KaragiannisMarco ValgimigliPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
The administration of bivalirudin after primary PCI significantly reduces residual stent strut thrombosis when compared to UFH. This observation should be considered hypothesis-generating since the heparin-treated patients were not randomly allocated.
Keyphrases
- percutaneous coronary intervention
- st segment elevation myocardial infarction
- acute coronary syndrome
- st elevation myocardial infarction
- acute myocardial infarction
- antiplatelet therapy
- coronary artery disease
- coronary artery bypass grafting
- end stage renal disease
- newly diagnosed
- venous thromboembolism
- ejection fraction
- atrial fibrillation
- chronic kidney disease
- coronary artery bypass
- pulmonary embolism
- growth factor
- emergency department
- heart failure
- optical coherence tomography
- diabetic retinopathy
- left ventricular
- patient reported outcomes
- electronic health record